Compared with normal tissues, PSMA4 was expressed at a much higher level in tumors, demonstrated by 36 analyses involving nine kinds of carcinomas, but six studies showed a reduced expression level of PSMA4 in breast cancer, leukemia, lymphoma and two other cancers. This evidence concerns the gene PSMA4 and carcinoma.